首页
登录
职称英语
Last year, when President George W. Bush announced that federal funds could b
Last year, when President George W. Bush announced that federal funds could b
游客
2025-01-03
28
管理
问题
Last year, when President George W. Bush announced that federal funds could be used to support re search on human embryonic stem cells, he mandated that only those cell lines that existed at the time would qualify for such support. More than a year later it’s becoming increasingly clear that these existing cell lines are inadequate. Unless more are created, the research slowdown may exact a staggering cost in terms of human suffering.
Since this announcement, the U. S National Institutes of Health has tried to stimulate research on the existing cell lines with new funding and efforts to streamline the initially cumbersome process of obtaining approved cells. However, whether there are 60 cell lines, as originally stated, or nine, as now appear to be available to NIH-funded investigators, the number is not adequate. Given the genetic diversity within the population, scientists need access to new cell lines if they are to come up with the most effective cell therapies.
The issue is partly one of safety. In conducting research with human participants, we must minimize risks. The most effective cell line might not be the safest. When developing a new medicine, a large number of molecules must be screened to find a balance between effectiveness and safety. The same is true with cells: In the context of cell therapy, it will be important to minimize unwanted immune reactions and inflammation. This requires selection from a large number of cell lines to obtain the best match.
It’s clear from experiments with animals that stem--cell therapies can reduce human suffering. Parkinsonian mice have been cured with embryonic stem cells that were programmed to become dopamine-secreting, replacement nerve cells. Soon, cells induced to make insulin in tissue cultures will be used in attempts to treat diabetic mice. Similar successes have been achieved in animal models of spinal cord injury, heart failure and other degenerative disorders. We are at a frontier in medicine where tissues will be re stored in ways that were not imaginable just a few years ago. The ethical issues raised by human-embryo research are profound. The human costs of restricting this research must be taken into account as well. The cost in dollars of delaying new stem-cell research is difficult to estimate. It might measure in the hundreds of billions of dollars, especially if one adds the lost productivity of individuals who must leave work to care for victims of degenerative disorders.
A less obvious, but real, cost is the damage to the fabric of America’s extraordinary culture of inquiry and technical development in biomedical science. Our universities and teaching hospitals are unparalleled. We attract the very best students, scientists and physicians from around the world. But these institutions are fragile. Research and education play key roles in attracting the best physicians. A crippled research enterprise might add an unbearable stress with long-lasting effects on the entire system. If revolutionary new therapies are delayed or outlawed, we could be set back for years, if not decades.
To steer clear of controversy, some investigators will redirect their research. Others will emigrate to countries where such research is allowed and encouraged. Some will drop out entirely. The pall cast over the science community could extend far beyond stem-cell research. Many therapies have emerged from collaboration between government-sponsored researchers and private enterprise. Few of these discoveries would have emerged ii, for instance, recombinant DNA research had been outlawed 30 years ago. We face the same type of decision today with limits placed on human embryonic stem cells.
Safeguards will be necessary. But if we do not proceed embracing the values of objective, open, inquiry with complete sharing of methods and results, the field will be left to less rigorous fringe groups here and abroad. Patients and society will suffer. [br] All of the following are the consequences of the research slowdown EXCEPT ______.
选项
A、the negative impact on technical advancement.
B、the detriment to the culture of inquiry.
C、the loss of one’s productivity.
D、the collapse of American dreams.
答案
D
解析
细节题。第四段末句指出:It might measure in the hundreds of billions of dollars,especially if one adds the lost productivity of individuals,[C]是一个后果。第五段首句提到:A less obvious,but real,cost is the damage to the fabric of America’s extraordinary culture of inquiry and technical development...,[B]和 [A]符合文意。只有[D]未提及,故为答案。
转载请注明原文地址:https://tihaiku.com/zcyy/3897365.html
相关试题推荐
Lastyear,whenPresidentGeorgeW.Bushannouncedthatfederalfundscouldb
Lastyear,whenPresidentGeorgeW.Bushannouncedthatfederalfundscouldb
Lastyear,whenPresidentGeorgeW.Bushannouncedthatfederalfundscouldb
[originaltext]TheAmericanVicePresidentDickCheneyhassaidheacceptsfu
[originaltext]TheAmericanVicePresidentDickCheneyhassaidheacceptsfu
In______,PresidentNixonmetMaoZedongandthetwocountriesissuedtheShang
[originaltext]TheTreasuryDepartmentannouncedtodaythatitisloweringth
"ThePresidentHonesty"refersto______.A、thebreak-inattheWatergatecomple
TheWatergateScandalin1973forced______toresign,thefirstpresidenttodo
[originaltext]PresidentGeorgeBushsayshewantstoshiftthedebateabout
随机试题
VOLAREGIFTSHOP343HedgeStreet,HickoryHills,IL60457www.volaregifts.com
Anothercriticalfactorthatplaysapartinsusceptibilitytocoldsisage.
按弹性理论,四边支承板在满足下列什么条件时应按双向板设计?( )A.l2/l1
图示结构受一对等值、反向、共线的力作用,自重不计,铰支座A的反力RA的作用线(
政策及程序给管理层和员工提供了行动指南。某跨国公司的内部审计师打算对一个高级管理
某男,67岁。腰痛,喜按喜揉,遇劳更甚,常心烦失眠,口燥咽干,面色潮红,手足心热
单人操作时不得进行()操作。(A)登高(B)登杆(C)解锁(D)接地
不属于商用房贷款操作风险的防控措施的是()A:降低贷前调查深度B:合理确定贷款
“有时我不得不回避我的情人们,以免他们互相发现”,这是一种()的爱情。 (
银行承兑汇票的承兑银行,应当按照票面金额向出票人收取()的手续费。A:千分之一
最新回复
(
0
)